Citations

Clear

426 citation(s) found for "ST, Reza".

Expression and purification of SARS-CoV-2 receptor binding domain in Escherichia coli for diagnostic and therapeutic purposes
Ghaderi, Hajarossadat , Shoari, Alireza , Salehi, Shima , Eskafi, Ayda Hassanzadeh, Cohan, Reza Ahangari , Moazzami, Reza, Salehi, Shima, Habibi‐Anbouhi, Mahdi , Behdani, Mahdi

Mayo Clinic

Research in Pharmaceutical Sciences | October 22, 2024 | Volume: 19 | Issue: 5 | Pages: 500-508

10.4103/rps.rps_93_23 | PMID 39691303 Get It

Background and purpose: SARS-CoV-2 causes a severe respiratory disease known as COVID-19 and is responsible for a global viral pandemic. The SARS-CoV-2 receptor binding domain (RBD) is located on the spike protein, which identifies and binds to the angiotensin-converting enzyme 2 (ACE2) receptor. The RBD is an important target for developing virus-neutralizing antibodies, vaccines, and inhibitors. Experimental approach: In this study, recombinant SARS-CoV-2 RBD was expressed in E. coli BL21 (DE3) and purified and its binding activity was determined. Purification was conducted using the Ni-NTA column. ELISA. flow cytometry assays were set to evaluate the binding ability of recombinant RBD to different anti-RBD antibodies and native ACE2 receptors on HEK293A cells, respectively. Findings/Results: The SDS-PAGE analysis revealed the corresponding band at 27 kDa in the culture after induction with 0.7 mM IPTG, while the corresponding band was not observed in the culture without IPTG induction. ELISA results showed that antibodies produced in the human sera could bind to the recombinant RBD protein and the commercial anti-RBD antibody. Also, flow cytometry analysis revealed that the recombinant RBD could bind to human ACE2 on the surface of HEK293A cells. Conclusion and implication: Our outcomes displayed that the recombinant RBD expressed in the E. coli strain has biological activity and can be used as an antigen for the development of diagnosis kits and vaccines as well as a tool for screening drugs against SASR-CoV-2.
Transcranial doppler (TCD) in predicting outcomes following successful mechanical thrombectomy of large vessel occlusions in anterior circulation: a systematic review and meta-analysis
Jazayeri, Seyed Behnam , Pirahanchi, Yasaman , Ravi, Vikas , Carrión‐Penagos, Julián , Bowers, Jeffrey, Modir, Royya , Agrawal, Kunal , Hemmen, Thomas , Meyer, Brett C. , Meyer, Dawn , Sabayan, Behnam , Bowers, Jeffrey, Agrawal, Kunal, Shahripour, Reza Bavarsad , Agrawal, Kush

Mayo Clinic

Journal of NeuroInterventional Surgery | October 18, 2024 | Volume: 17 | Issue: 12 | Pages: 1325-1332

10.1136/jnis-2024-022457 | PMID 39424305 Get It

Background Transcranial Doppler (TCD) is a non-invasive, bedside tool that allows for real-time monitoring of the patient’s hemodynamic status following mechanical thrombectomy (MT). This systematic review and meta-analysis aims to evaluate the predictive value of TCD parameters following successful MT (Thrombolysis in Cerebral Infarction 2b–3). Methods In July 2024, we searched PubMed, Embase, and Scopus, to identify observational studies in which TCD parameters were measured within 48 hours of MT. Using random-effects models, we compared four TCD parameters (mean flow velocity (MFV), MFV index, pulsatility index (PI), and peak systolic velocity (PSV) among groups with vs without hemorrhagic transformation (HT) and favorable vs poor functional recovery (modified Rankin Scale 0–2 vs 3–6). Results Eleven studies comprising 1432 patients (59% male; mean age range: 63–73 years) were included. The MFV and MFV index were higher in patients with HT (Hedges' g=0.42 and 0.54, P=0.015 and 0.005, respectively). Patients with MFV index ≥1.3 showed a higher risk of all HT (RR 1.97; 95% confidence interval (CI) 1.28 to 3.03, P=0.002), symptomatic HT (RR 4.68; 95% CI 1.49 to 14.65, P=0.008), and poor functional status at 90 days (RR 1.65; 95% CI 1.27 to 2.14, P=0.029), respectively. There was no difference in mean PSV (P=0.1) and PI (P=0.3) among groups with and without HT. Conclusion This study underscores the prognostic value of the MFV index in predicting HT, symptomatic HT, and poor functional recovery after successful MT in the anterior circulation. Large-scale, multi-center studies are necessary to confirm these findings and to validate the MFV index as a reliable predictor for improving post-thrombectomy care.
Lipoprotein (a) as a Cardiovascular Risk Factor in Controversial Clinical Scenarios: A Narrative Review
Abdalla, Hesham, Mahmoud, Ahmed , Khedr, Ahmed E. , Farina, Juan M. , Scalia, Isabel G. , Abbas, Mohammed Tiseer , Awad, Kamal A., Ali, Nima Baba , Bismee, Nadera N. , Esfahani, Sogol Attaripour , Javadi, Niloofar , Pereyra, Milagros , Alsidawi, Said , Lester, Steven J., Ayoub, Chadi , Arsanjani, Reza , Abdalla, Hesham M, Mahmoud, Ahmed K , Baba Ali, Nima , Attaripour Esfahani, Sogol, Arsanjani, Reza , Farina, Juan M , Pereyra, Milagros , Alsidawi, Said , Scalia, Isabel G , Abbas, Mohammed Tiseer

Mayo Clinic

International Journal of Molecular Sciences | October 14, 2024 | Volume: 25 | Issue: 20 | Pages: 11029

10.3390/ijms252011029 | PMID 39456811 Get It

Lipoprotein (a) is a complex lipid molecule that has sparked immense interest in recent years, after studies demonstrated its significant association with several cardiovascular conditions. Lp(a) promotes cardiovascular disease through its combined proatherogenic, pro-inflammatory, and prothrombotic effects. While the measurement of Lp(a) has become widely available, effective methods to reduce its concentration are currently limited. However, emerging data from ongoing clinical trials involving antisense oligonucleotides have indicated promising outcomes in effectively reducing Lp(a) concentrations. This may serve as a potential therapeutic target in the management and prevention of myocardial infarction, calcific aortic stenosis, and cerebrovascular accidents. In contrast, the role of Lp(a) in atrial fibrillation, in-stent restenosis, cardiac allograft vasculopathy, and bioprosthetic aortic valve degeneration remains unclear. This review article aims to thoroughly review the existing literature and provide an updated overview of the evidence surrounding the association of Lp(a) and these cardiovascular diseases. We seek to highlight controversies in the existing literature and offer directions for future investigations to better understand Lp(a)’s precise role in these conditions, while providing a summary of its unique molecular characteristics.
Defining standards for fluoroscopy in gastrointestinal endoscopy using Delphi methodology
Khalaf, Kareem , Pawlak, Katarzyna M. , Alkandari, Asma , Baron, Todd H. , Bechara, Robert , Binda, Cecilia , Chen, Yen‐I , Moura, Eduardo Guimarães Hourneaux de , Forbes, Nauzer , James, Paul, Martin, Harry , May, Gary R. , Mosko, Jeffrey D. , Oyeleke, Ganiyat K. , Petersen, Bret T. , Saxena, Payal , Sethi, Amrita , Sharaiha, Reem Z. , Tang, Raymond S. , Villarroel, Mariano , Hooft, Jeanin E. van , Renteln, Daniel von , Walsh, Catharine M. , Aberin, Tricia, Banavage, Dawn, Chen, Jowell Akina, Clancy, James, Drake, Heather, Im, Melanie, Low, Chooi Peng, Myszko, Alexandra, Navarro, Krista, Redman, Jessica, Reyes, Wayne, Weinstein, Faina, Na, Caleb, Tham, Daniel , He, Tony , Malipatil, Sharan B., Gimpaya, Nikko , Kundra, Arjun , Grover, Samir C. , Barkun, Alan N , Bechara, Robert , Binda, Cecilia , de Moura, Eduardo , Hassan, Cesare , Kahaleh, Michel , Sharaiha, Reem Z , Villarroel, Mariano , van Hooft, Jeanin E , Voermans, Rogier P , von Renteln, Daniel , Walsh, Catharine M , Gupta, Sunil , Fujiyoshi, Yusuke , Grover, Samir C , Causada Calo, Natalia S , Pawlak, Katarzyna M , Adler, Douglas G. , Barkun, Alan , Berzin, Tyler M. , Cai, Ming‐Yan , Carrara, Silvia , Fugazza, Alessandro , Hassan, Cesare , James, Paul D., Kahaleh, Michel , Maselli, Roberta , Repici, Alessandro , Spadaccini, Marco , Teshima, Christopher , Voermans, Rogier P. , Clancy, James, Reyes, Wayne, Gupta, Sunil , Mokhtar, Ahmed H., Gholami, Reza

Mayo Clinic

Endoscopy International Open | October 7, 2024 | Volume: 12 | Issue: 11 | Pages: E1315-E1325

10.1055/a-2427-3893 | PMID 39559412 Get It

Abstract Background and study aims Use of fluoroscopy in gastrointestinal endoscopy is an essential aid in advanced endoscopic interventions. However, it also raises concerns about radiation exposure. This study aimed to develop consensus-based statements for safe and effective use of fluoroscopy in gastrointestinal endoscopy, prioritizing the safety and well-being of healthcare workers and patients. Methods A modified Delphi approach was employed to achieve consensus over three rounds of surveys. Proposed statements were generated in Round 1. In the second round, panelists rated potential statements on a 5-point scale, with consensus defined as ≥80% agreement. Statements were subsequently prioritized in Round 3, using a 1 (lowest priority) to 10 (highest priority) scale. Results Forty-six experts participated, consisting of 34 therapeutic endoscopists and 12 endoscopy nurses from six continents, with an overall 45.6% female representation (n = 21). Forty-three item statements were generated in the first round. Of these, 31 statements achieved consensus after the second round. These statements were categorized into General Considerations (n = 6), Education (n = 10), Pregnancy (n = 4), Family Planning (n = 2), Patient Safety (n = 4), and Staff Safety (n = 5). In the third round, accepted statements received mean priority scores ranging from 7.28 to 9.36, with 87.2% of statements rated as very high priority (mean score ≥ 9). Conclusions This study presents consensus-based statements for safe and effective use of fluoroscopy in gastrointestinal endoscopy, addressing the well-being of healthcare workers and patients. These consensus-based statements aim to mitigate risks associated with radiation exposure while maintaining benefits of fluoroscopy, ultimately promoting a culture of safety in healthcare settings.
Application of transcranial Doppler in the diagnosis and management of cervical artery dissection: Insights from a multicenter survey within the STOP‐CAD study
Guo, Xiaofan , Shifflett, Benjamin , Khan, Muhib , Rothstein, Aaron , Khazaal, Ossama , Elnazeir, Marwa , Hansra, Harjot, Meyer, Brett C. , Guo, Xiaofan , Sabayan, Behnam , Antonenko, Kateryna , Heldner, Mirjam R. , Romoli, Michele , Marto, João Pedro , Keser, Zafer , Meyer, Dawn , Shahripour, Reza Bavarsad

Mayo Clinic

Clinical Neuroimaging | October 4, 2024 | Volume: 1 | Issue: 1-2 | Pages: No page available

10.1002/neo2.70004 Get It

AbstractBackgroundCervical artery dissection (CAD) is a common cause of ischemic stroke in young adults. Local blood clot formation and distal emboli are the key mechanisms for the development of stroke in patients with CAD. Microemboli distal to the dissection point can be detected as high‐intensity transient signals (HITS) using transcranial Doppler (TCD). Despite this unique capability, TCD is used inconsistently in the management of CAD. In this international survey, we aim to explore the frequency and potential barriers to TCD use in CAD.MethodThis study was an international electronic survey, based on the Antithrombotic Treatment for Stroke Prevention in Cervical Artery Dissection (STOP‐CAD) study, aiming at evaluating the use of TCD in diagnosing and managing CAD patients. A comprehensive questionnaire was developed to gather insights into the current practices, perceptions, and potential barriers to the effective use of TCD in participating centers. The collected data was then analyzed.ResultsFifty‐eight medical centers with advanced stroke care capabilities from Europe and United States participated in this study. Half (29 out of 58) of the sites routinely perform TCD on CAD patients, particularly in the presence of carotid or vertebral artery stenosis, complete carotid occlusion, and early neurologic deterioration. The primary reason for participating institutions not performing TCD was because its results would not change their practice. The protocol for TCD monitoring and managing HITS‐positive CAD patients varied among centers but transitioning from antiplatelet to anticoagulant was the most common practice in this patient population.ConclusionHalf of the stroke centers in our survey routinely perform TCD monitoring for CAD patients. The detection of HITS in CAD patients is a warning sign for providers, which may prompt a change in secondary stroke prevention management. However, a standard protocol for performing TCD in CAD and treatment recommendations for HITS‐positive CAD are not currently available, which warrants further research.
eQTL in diseased colon tissue identifies novel target genes associated with IBD
Furey, Terrence S. , Nishiyama, Nina C. , Silverstein, Sophie , Darlington, Kimberly , Ng, Meaghan Kennedy, Clough, Katelyn , Bauer, Mikaela J., Beasley, Caroline, Bharadwaj, Akshatha, Ganesan, Rajee , Lau, Gwen, Lian, Grace , Rahbar, Reza, Sadiq, Timothy S., Schaner, Matthew R. , Stem, Jonathan, Friton, Jessica, Faubion, William A. , Sheikh, Shehzad Z. , Ng, Meaghan M. Kennedy , Kapadia, Muneera Rehana

Mayo Clinic

No container title available | October 3, 2024 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-5147457/v1 Get It

Abstract Genome-wide association studies (GWAS) have identified over 300 loci associated with the inflammatory bowel diseases (IBD), but putative causal genes for most are unknown. We conducted the largest disease-focused expression quantitative trait loci (eQTL) analysis using colon tissue from 252 IBD patients to determine genetic effects on gene expression and potential contribution to IBD. Combined with two non-IBD colon eQTL studies, we identified 194 potential target genes for 108 GWAS loci. eQTL in IBD tissue were enriched for IBD GWAS loci colocalizations, provided novel evidence for IBD-associated genes such as ABO and TNFRSF14, and identified additional target genes compared to non-IBD tissue eQTL. IBD-associated eQTL unique to diseased tissue had distinct regulatory and functional characteristics with increased effect sizes. Together, these highlight the importance of eQTL studies in diseased tissue for understanding functional consequences of genetic variants, and elucidating molecular mechanisms and regulation of key genes involved in IBD.
Computed Tomography Evaluation of Coronary Atherosclerosis: The Road Travelled, and What Lies Ahead
Ayoub, Chadi , Scalia, Isabel G. , Anavekar, Nandan S., Arsanjani, Reza , Jokerst, Clinton, Kritharides, Leonard , Kritharides, Leonard , Arsanjani, Reza , Scalia, Isabel G , Chow, Benjamin J.W.

Mayo Clinic

Diagnostics | September 23, 2024 | Volume: 14 | Issue: 18 | Pages: 2096

10.3390/diagnostics14182096 | PMID 39335775 Get It

Coronary CT angiography (CCTA) is now endorsed by all major cardiology guidelines for the investigation of chest pain and assessment for coronary artery disease (CAD) in appropriately selected patients. CAD is a leading cause of morbidity and mortality. There is extensive literature to support CCTA diagnostic and prognostic value both for stable and acute symptoms. It enables rapid and cost-effective rule-out of CAD, and permits quantification and characterization of coronary plaque and associated significance. In this comprehensive review, we detail the road traveled as CCTA evolved to include quantitative assessment of plaque stenosis and extent, characterization of plaque characteristics including high-risk features, functional assessment including fractional flow reserve-CT (FFR-CT), and CT perfusion techniques. The state of current guideline recommendations and clinical applications are reviewed, as well as future directions in the rapidly advancing field of CT technology, including photon counting and applications of artificial intelligence (AI).
Meta‐analysis: Risk of lymphoma in patients with inflammatory bowel disease in population‐based cohort studies
Alizadeh‐Tabari, Shaghayegh , Singh, Siddharth, Ananthakrishnan, Ashwin N. , Malekzadeh, Reza , Talley, Nicholas J. , Talley, Nicholas J. , Zamani, Mohammad , Murad, Mohammad Hassan, Ananthakrishnan, A N , Malekzadeh, Reza , Zamani, Mohammad , Murad, M. Hassan

Mayo Clinic

Alimentary Pharmacology & Therapeutics | September 23, 2024 | Volume: 60 | Issue: 10 | Pages: 1264-1275

10.1111/apt.18277 | PMID 39310939 Get It

Summary Background There are inconsistencies in the results of the studies investigating the association between inflammatory bowel disease (IBD) and lymphoma. Aims The aim of this study is to systematically appraise the risk of lymphoma development in patients with IBD. Methods We searched Embase, PubMed and Scopus from inception to 30 April 2024 to identify population‐based cohort studies that evaluated the risk of lymphoma in patients with IBD in comparison with those without IBD. We carried out random‐effects meta‐analyses and estimated pooled relative risks (RRs) with 95% confidence intervals (CIs). Results We identified 23 eligible studies reporting 2078 lymphoma events in 656,731 patients with IBD. Patients with IBD had 30% higher odds of lymphoma (RR = 1.30 [95% CI: 1.21–1.40]). The risk of developing both Hodgkin's lymphoma (nine studies, RR = 1.29 [95% CI: 1.06–1.53]) and non‐Hodgkin's lymphoma (16 studies, RR = 1.31 [95% CI: 1.20–1.42]) was increased in patients with IBD (p for interaction = 0.881). The increased risk of lymphoma was observed in both Crohn's disease (17 studies, RR = 1.54 [95% CI: 1.27–1.80]) and ulcerative colitis (20 studies, RR = 1.22 [95% CI: 1.09–1.35]) (p for interaction = 0.026). Meta‐regression demonstrated that mean age of patients, study year, mean study follow‐up duration, and percentages of immunomodulators and biologics use did not influence study outcome. Conclusions The risk of lymphoma is only modestly increased in patients with IBD, with Crohn's disease having a slightly higher risk than ulcerative colitis. In IBD, there appears to be no difference between the risks of Hodgkin's and non‐Hodgkin's lymphoma.
Rapid development of severe mitral regurgitation following tricuspid valve intervention
Abdalla, Hesham, Arsanjani, Reza, Alsidawi, Said , Nkomo, Vuyisile, Alsidawi, Said , Nkomo, Vuyisile T. , Arsanjani, Reza

Mayo Clinic

European Heart Journal - Cardiovascular Imaging | September 19, 2024 | Volume: 26 | Issue: 1 | Pages: 148-149

10.1093/ehjci/jeae244 | PMID 39295524 Get It

Representing Part-Whole Hierarchies in Foundation Models by Learning Localizability, Composability, and Decomposability from Anatomy via Self-Supervision
Taher, Mohammad Reza Hosseinzadeh , Gotway, Michael B. , Liang, Jianming

Mayo Clinic

2024 IEEE/CVF Conference on Computer Vision and Pattern Recognition (CVPR) | September 16, 2024 | Volume: No volume available | Issue: No issue available | Pages: 11269-11281

10.1109/cvpr52733.2024.01071 | PMID 39670210 Get It